Home News General Newcastle disease workshop to provide learning opportunities between Africa and South Asia

Photograph: James Glossop for The Times Sakuntala Shlwakoti vaccinates a chicken against Newcastle disease using an eye-drop in the village of Khundunabayi Gabesha Chowk in Jhapa, Nepal. In the country, an Edinburgh-based charity backed by the Bill & Melinda Gates Foundation, works to improve animal health and consequently human lives through animal disease vaccination programmes. Specifically, they target Newcastle Disease, which blights backyard poultry, killing 90%+ of the flock year after year. April 2014.

A Newcastle Disease (ND) workshop will be held on 12-14 March in India to facilitate cross learning between our African and Asian Newcastle vaccination projects. The event is organised by GALVmed. The event will be attended by our project partners (including manufacturers and animal healthdistributers) and project managers.

The objective of the workshop will be to review the different aspects of the ND projects and their impacts in Asia and Africa.  Attendees will also visit project in Mandu, Ramgadh in Jharkhand to see first hand how vaccinations are done. GALVmed project partners will also share experiences on different aspects of the ND work during the visit.

The workshop is expected to create a clear understanding to enhance ND vaccination scale-up for the benefit of village poultry producers in Africa and to produce a clear indicator to measure the progress of the ND vaccination adoption.

Our Newcastle project in India has been running for several years and we’re currently partnered with Heifer International and SAMPARK in India to provide 145,000 households with the vaccine. Our South Asia project uses the Thermostable Lasota vaccine, which was developed with collaboration from Hester Biosciences, an Indian company manufacturing animal vaccines and health products..

Our Africa-based ND project has secured a manufacturing partner, MCI Santé Animale in Morocco, who will be producing the vaccine for African countries this year. Our Africa project uses the thermostable I-2 vaccine and was developed in collaboration with Professor Philemon Wambura of Sokoine University of Agriculture in Tanzania. The vaccine will be available in the following countries in East Africa: Kenya, Tanzania and Uganda. The vaccine is already being used in the following North, Central and West African countries: Burkina Faso, Cameroon, Democratic Republic of Congo, Ivory Coast, Mali, Morocco, Niger and Senegal.

For more information on our work follow us on @GALVmed. Follow the workshop conversation on Twitter #NDvaccine from 12-14th March.

Learn more about our Newcastle Disease project.